Leandro Gabriel Mieravilla Email & Phone Number

Montreal, Qc, Ca

Montreal, Canada

•Biotechnology and Pharmaceutical Product Development: Engaged in business development, marketing plan, implementing tactics, pre/post launch activities, for biotechnology, biosimilar and generics. Manage assigned expense budgets.•Lead: brand team and collaborate cross-functionally for assigned product(s) to support commercial planning and achievement of corporate objectives•Licensing out/In and Partner Evaluation: Identifying and evaluating potential partners through market research, discovering growth opportunities, and exploring novel areas of innovation, in Canada, USA, European, and Latin American markets.•Key responsibilities: development of the marketing plan, implementing tactics consistent with the overall brand strategy and communication: with internal and external stakeholders/customers in order to align the strategic and tactical direction of brand projects with the overall brand strategy.•Strategic and Risk Analysis: Conducting strategic and risk analyses to define business opportunities for biosimilar, biotechnology, generic and natural health products.•Market Research and Opportunity Identification: Conducting start-up activities, market research, pre-launch and launching products and identifying industry opportunities for new and established products.•Product Development and Partnerships: Leading product development efforts, negotiating strategic alliances and licensing agreements with biopharmaceutical and generic companies.•Financial Performance and Team Management: Achieving an annual turnover of USD 12 million and managing a team of 4 people.•www.cassara.com.ar

Montreal, Canada Area

•Commercial Agreements: Established commercial agreements between pharmaceutical companies for biotechnology and generic products.•Out/In-Licensing and Business Development: Focused on licensing in/out and business development for biosimilar, generic and prescription (RX) products.•Sales Growth: Achieved significant sales increases of $1.9 million in 2008, $2.5 million in 2009, $8 million in 2010, and $9.1 million in 2011.•Market Research and Client Acquisition: Conducted market research and identified new launch opportunities by evaluating risks. Acquired new clients through public relations and business development activities.•Professional Experience: Initially worked at AQVA from March 2005 to December 2005.

Colombia

•Logistics Solutions Development: Led the development of logistics solutions in new markets for biotechnology, biosimilar, and pharmaceutical products.•Business and sales Channel Expansion: Engaged with Contract Research Organizations (CROs) to establish new sales channels locally and globally.•Strategic Alliances: Established new strategic alliances with airlines for both domestic and international services.•Proactively monitor analyzed and interpreted market trends and recommended strategies to adapt to a changing environment.•Financial Planning and Analysis: Developed and monitored forecasts, budgets, and business plans.•Team Management: Managed team of 120 staff members.

El Salvador, Central America

•Market Development: Developed the biotechnology, generic, and prescription (Rx) product markets opportunities in Central America and Caribbean regions, including Guatemala, Belize, Honduras, El Salvador, Dominican Republic, Cuba, Mexico, and Panama.•Licensing and Partnerships: Led licensing activities for pharmaceutical products, identifying partners and potential clients.•Strategic Market Analysis: Conducted strategic market analysis for Central America and Caribbean regions.•Sales Growth: Achieved sales increase of $950 thousand in 2004 compared to 2003.•Business Development Supervision: Supervised and provided training in the business development area of subsidiaries within the region.•Team Management: Managed team of 70 staff members.

Argentina

•E-Business Product Development: Collaborated with medical associations to develop new e-business products aimed at facilitating the reception, evaluation, and management of medical studies for presentation at medical conferences.•Healthcare Communications: Created newsletters for healthcare professionals tailored to various specialties and developed medical educational programs.

Asia & Pacific And Latin America Region

•Successful Product Launches: Achieved and led successful introduction of Enbrel and Benefix developing local and global marketing plans, managing assigned expense budgets, implementing tactics, at multiple markets, including Japan, Australia, India, Malaysia, Pakistan, Hong Kong, Germany, Brazil, Chile, Colombia, Venezuela, and Mexico, within the immunology and hemophilia sectors doing premarketing and launches activities.•Cross-Functional Leadership: Led and coordinated activities across medical, research and development, regulatory, production, and patient support departments.•Global and Strategic Analysis: Conducted comprehensive strategic analysis for the Asia-Pacific and Latin America regions for Enbrel, Benefix, and Refacto.•Notable Achievements:•Benefix (Hemophilia): Achieved record global sales of $190 million with an annual operating budget of $20 million in 2000; recorded sales of $1.2 million in Argentina with an annual operating budget of $100 thousand.•Enbrel (Etanercept): Achieved record global sales of $650 million with an annual operating budget of $65 million in 2000; recorded sales of $3.6 million in Argentina with only 6,654 units sold in 2001, marking a 260% increase over 2000, with an annual operating budget of $350 thousand.•Team Management: Managed global team of 15 staff members.

Argentina

•Specialty Oversight: Managed the following specialties: Urology, Oncology, Infectious Diseases, and Cardiology.•Cross-Department Coordination: Coordinated activities with the Medical and Sales departments.•Product Launch Development: Developed pre-launch and post-launch activities for Tiadyl.•Event Organization: Organized a launch convention in the United States for a cardiology product.•Notable Achievements: Tiadyl (Candesartan): Achieved sales of USD 1.8 million and Norvir (First Protease Inhibitor): Achieved sales of USD 2.5 million.

Member

Activities and Societies: BD activities among pharmaceutical and biotechnology companies worldwide

European Union Market Business Development, Graduated

Activities and Societies: Global business development

Risk Management, International Business, L´Indemnisation Dans Les Conventions De Licence: Gestion De Risq - Graduated

Activities and Societies: Biosimilar meetings

Biosimilar And Biotechnology Import And Export Operations (Canada), Biosimilar And Biotechnology Import And Export Operations

Nafta Biotechnology Products Business, Nafta Biotechnology Products Business

Author'S Licensing And Rights, Business Development, Graduated In Licensing

Tennis Coach, Sports Business, Tennis Coach

Tennis Coach, Sports Business, Tennis Coach

Master'S Degree, Business Administration And Management, General

Ba, Business, Ba In Business Administration

Business development

Mba, Business

Activities and Societies: CEMA University Ambassador for Canada Founder and first President of CEMA University Alumni Association.